Super Agents for Pharmaceutical Sales, Medical, and Training Workflows
Harnessing the power of GenAI to advance medical training and implementation.
Project Overview
Updated January 7, 2026
The Problem
The pharmaceutical industry faces significant challenges with sales efficiency, healthcare provider engagement and workforce training. Current solutions have proven inefficient and difficult to scale. Many rely on the manual curation of training content as well as static, fragmented customer data management systems. Broader technological advances have not been applied, such as real-time decision support and AI-driven workflow automations tailored to the pharmaceutical industry. Together, these challenges are limiting the ability of pharmaceutical companies to make products available to more patients as well as share their medical knowledge.
How We Are Solving It
ACTO, in collaboration with Metrix Group, Advanz Pharma, and Veloxis Pharmaceuticals, is leading an initiative to revolutionize pharmaceutical sales and training through AI-driven workflow optimization. At the core of this work is the development of two AI-powered agents for sales representatives and commercial team training. The expanded LAICA solution will integrate multi-source AI-driven decision support to automate sales workflows and dynamically generate training content. The AI agents will be trained, tested, and deployed in real-world environments with partners Advanz Pharma and Veloxis Pharmaceuticals. This project also integrates deep industry insights from partners, including Metrix Group. The outcome will be faster drug launches and broader market access, so Canadian patients can receive new treatments more efficiently.
